Image 1_Global, regional, and national burden of ischemic heart disease in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2021: a systematic analysis o... by Weixin Sun (10116991)

“…Major risk factors included high low-density lipoprotein cholesterol, smoking, and high systolic blood pressure. Projections suggest a global decline in IHD burden, with decreasing incidence and deaths across both sexes by 2050.…”

Table 2_Global, regional, and national burden of ischemic heart disease in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2021: a systematic analysis o... by Weixin Sun (10116991)

“…Major risk factors included high low-density lipoprotein cholesterol, smoking, and high systolic blood pressure. Projections suggest a global decline in IHD burden, with decreasing incidence and deaths across both sexes by 2050.…”

Table 1_Global, regional, and national burden of ischemic heart disease in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2021: a systematic analysis o... by Weixin Sun (10116991)

“…Major risk factors included high low-density lipoprotein cholesterol, smoking, and high systolic blood pressure. Projections suggest a global decline in IHD burden, with decreasing incidence and deaths across both sexes by 2050.…”

Effect of group and airway size on L1 thickness (A), L2 thickness (B), ratio L2 area/Pi (C), and ratio L2 area/Pi2 (D) in <i>in vivo</i> EBUS. by Michela Bullone (792819)

Foot-off times from the 1, 2(an hour later) and 3(a week later) test session for the elderly and younger group of subjects, respectively, across 6 trials and Task conditions: singl... by Itshak Melzer (75733)

“…A similar decrease is seen under dual task conditions for the third test session. …”

Table_1_Prediction of prognosis in patients with nontraumatic intracranial hemorrhage using blood urea nitrogen-to-creatinine ratio on admission: a retrospective cohort study based... by Peng Chen (6514)

“…Background<p>The blood urea nitrogen-to-creatinine ratio (BUNCR) has been proposed as a potential biomarker for critical illness-induced catabolism. …”

NDY1/KDM2B, EZH2 JARID2 and JMJD3 control the expression of GFI1, a direct repressor of the HCMV MIEP, by regulating histone H3K27 tri-methylation in the GFI1 promoter. by George Sourvinos (191166)

“…Bars in the lower panel show the relative EGFP fluorescence in the indicated cells (mean ± SD). <b>D</b>. The knockdown of NDY1/KDM2B, EZH2 and JARID2 decrease the abundance of histone H3K27me3 in a negative regulatory domain of the GFI1 promoter (site # 1). …”

The relation between the degree of de-efferentation in the inner hair cell area and loss of afferent synapses (A) or ABR Wave 1 amplitude (B) is similar whether the de-efferentatio... by M. Charles Liberman (275402)

“…Data are not shown for <i>TMx ipsi</i> and <i>OM ipsi</i> groups since conductive hearing loss, <i>per se</i> profoundly decreases ABR amplitudes. Groups and group sizes are as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142341#pone.0142341.g002" target="_blank">Fig 2</a>. …”

Long-term effect of motor cortex stimulation in patients suffering from chronic neuropathic pain: An observational study by Dylan J. H. A. Henssen (4807557)

“…<div><p>Background</p><p>Motor cortex stimulation (MCS) was introduced as a last-resort treatment for chronic neuropathic pain. …”

Transfection efficiency corrected ³H-gemcitabine uptake in HEK293 (A), AsPC-1 (B), and MIA PaCa-2 (C) cells with or without transfection of hCNT3 cDNA. by Robert J. Paproski (282968)

“…Uptake values were corrected for transfection efficiency as described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0056423#s2" target="_blank">methods</a> section. …”

Cell viability in HepG2 cells: HepG2 cells were pre-treated with lovastatin for 24h before everolimus was added, and the combination of both drugs was incubated for 48h (A) or 120h... by Svenja Nölting (566453)

“…(A) Treatment with 5–20 μM lovastatin or with 10 nM everolimus alone significantly decreased HepG2 cell viability. …”

Strong matrix metalloproteinase (MMP)-2/9-related near-infrared fluorescent (NIRF) signal in and around the ligated area of the left common carotid artery (LCA) of ApoE<sup>-/-</su... by Ik Jae Shin (387313)

“…<p>Two weeks after partial ligation of the LCA, there is a gradient of MMP-related fluorescence (mean intensity / tissue area in a rectangular region of interest) that is maximal close to the ligation site / bifurcation point (A, LCA C1 or C2), and progressively decreased as one move inferiorly closer to the arch both on the right and on the left, but the maximum is much higher on the ligated left side (A and B). …”

Short-term beat-to-beat temporal variability of the RR (STV_RR) and QT (STV_QT) intervals in age-matched controls and professional soccer players before and fol... by Csaba Lengyel (353113)

“…<p>Soccer players had a significantly higher STV_RR compared to controls before the game. …”

Data Sheet 1_Application of machine learning based on habitat imaging and vision transformer to predict treatment response of locally advanced esophageal squamous cell carcinoma fo... by Shu-Han Xie (17902661)

“…</p>Conclusion<p>The ExtraTrees model leveraging habitat imaging and ViT offered a non-invasive and accurate method to predict pathological response to nICT, guiding personalized treatment strategies, and decreasing the risk of immune-related adverse effects.…”

Table_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”

Image_7_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”

Table_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”

Image_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”

Image_8_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”

Image_4_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”